← Leaderboards
Hua Yu
Fzata, Inc.
$1,028,969
Attributed
$2,057,937
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $950.5K · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$2,057,937 · 1
By mechanism
R44$2,057,937 · 1
Top collaborators
- Zhiyong Yang3 shared
Others in their field
Other Emerging Leaders on “Efficacy Evaluation”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beth Baseler · Leidos Biomedical Research, Inc.$83,440,795
- Yunda Huang · Fred Hutchinson Cancer Center$73,762,513
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Julie Ake · National Institute Of Allergy And Infectious Diseases$50,742,120
- Ryan Cirz · Revagenix, Inc.$37,226,959
Research focus
Efficacy EvaluationEnsureDrug KineticsDysbiosisAdultEfficacy StudyAdoptive TransferCrohn&AposAcuteAnimal Disease ModelsBiochemicalAnimalsAntibodiesDesignBispecific AntibodiesAnalytical MethodBusinessesAttentionChronicBacteriaClinicClinical DevelopmentColitisExcretory Function